TABLE 3.
Gib2-interacting proteins identified through GST-Gib2 affinity purification combined with mass spectrometry
Please see “Experimental Procedures” for detailed description. Data shown were the unique proteins from combined extracts of C. neoformans var. grubii (H99) and var. neoformans (gpa1).
CCPR_CRYNE; cytochrome c peroxidase, mitochondrial; C. neoformans |
EF1A_CRYNE; elongation factor 1-α; C. neoformans |
IF4A_CRYNE; ATP-dependent RNA helicase eIF4A; C. neoformans |
Q2XPZ3_CRYNV; eukaryotic ADP/ATP carrier; C. neoformans |
Q5KQ18_CRYNJ CRYNE; putative prohibitin PHB1; C. neoformans |
Q55IY2_CRYNE; putative ribosomal protein L4; C. neoformans |
Q55KS9_CRYNE; putative uncharacterized protein (pyruvate decarboxylase); C. neoformans |
Q55MH3_CRYNE; UDP-glucose dehydrogenase; C. neoformans |
Q55NI0_CRYNE; 40 S ribosomal protein S7; C. neoformans |
Q55SW7_CRYNE; ATP synthase γ chain; C. neoformans |
Q55W79_CRYNE; conserved hypothetical protein (mucin-like glycoprotein); C. neoformans |
Q55Y63_CRYNE; endothelin-converting enzyme 1; C. neoformans |
Q55ZV5_CRYNE; putative uncharacterized protein (elongation factor 1-γ); C. neoformans |
Q561E6_CRYNE; T-complex protein 1 ϵ subunit; C. neoformans |
Q561J1_CRYNE; putative proteolysis- and peptidolysis-related protein; C. neoformans |
Q5K7I1_CRYNE; expressed protein (Pfam exo-endo-phos); C. neoformans |
Q5K7W8_CRYNE; 60 S ribosomal protein L13; C. neoformans |
Q5K9S1_CRYNE; hypothetical protein (SNARE protein YKT6); C. neoformans |
Q5KAF2_CRYNE; 60 S ribosomal protein L4e; C. neoformans |
Q5KBW9_CRYNE; 60 S ribosomal protein L19, putative; C. neoformans |
Q5KDP3_CRYNE; glucose-6-phosphate 1-dehydrogenase; C. neoformans |
Q5KE76_CRYNE; hypothetical protein; C. neoformans |
Q5KEJ6_CRYNE; 60 S acidic ribosomal protein P0; C. neoformans |
Q5KFA0_CRYNE; Putative ketol-acid reductoisomerase; C. neoformans |
Q5KFT4_CRYNE; electron transporter, transferring electrons within CoQH2-c; C. neoformans |
Q5KFU0_CRYNE; ATP synthase subunit β; C. neoformans |
Q5KGN7_CRYNE; putative Ran small monomeric GTPase; C. neoformans |
Q5KJB0_CRYNE; putative response to stress-related protein; C. neoformans |
Q5KJK1_CRYNE; putative zinc-binding dehydrogenase; C. neoformans |
Q5KKA2_CRYNE; hypothetical protein; C. neoformans |
Q5KKL4_CRYNE; hypothetical protein (putative sugar kinase); C. neoformans |
Q5KL26_CRYNE; ATP synthase, putative; C. neoformans |
Q5KLL1_CRYNE; 40 S ribosomal protein s3ae-a; C. neoformans |
Q5KLS4_CRYNE; cytoplasm protein, putative; C. neoformans |
Q5KN57_CRYNE; putative NADH dehydrogenase; C. neoformans |
Q5KNI6_CRYNE; putative 60 S ribosomal protein I7; C. neoformans |
Q5KP06_CRYNE; actin; C. neoformans |
Q5KP62_CRYNE; S-adenosylmethionine synthetase; C. neoformans |
Q5KPZ1_CRYNE; putative ribosomal protein S3; C. neoformans |
Q6XX21_CRYNV; flavohemoglobin; C. neoformans |
Q7Z875_CRYNV; elongation factor 1-α; C. neoformans |
Q85SZ4_CRYNV; cytochrome c oxidase subunit 2; C. neoformans |
Q8NKG5_CRYNE; sn-glycerol-3-phosphate dehydrogenase NAD+; C. neoformans |
Q5KGM8_CRYNE; 60 S ribosomal protein L6; C. neoformans |
Q5KAP9_CRYNE; putative uncharacterized protein; C. neoformans |
Q5KJP2_CRYNE; putative voltage-dependent ion-selective channel; C. neoformans |
Q560D1_CRYNE; putative uncharacterized protein; C. neoformans |